Top compounds associated with response to TPH2


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan CTRPv2 pan-cancer AAC 0.025 0.4
mRNA Bicalutamide GDSC1000 pan-cancer AAC 0.025 0.4
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.036 0.4
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA KU-55933 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA MK-2206 GDSC1000 pan-cancer AAC 0.027 0.4
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.027 0.4
Download CSV